secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0001628280-21-022408
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel Q3 revenue up 7% to $34.5M; guides FY2021 revenue $158-$161M
--------------------------------------------------------------------

- Q3 total net revenue $34.5M (+7% YoY); MACI $23.9M, Epicel $9.8M (+48% YoY).
- Q3 net loss $4.9M ($0.11/sh) vs net income $3.6M in Q3 2020; non-GAAP adj. EBITDA $4.3M.
- FY2021 guidance: revenue $158-$161M (27-30% YoY growth); gross margin ~70%; adj. EBITDA margin ~22%.
- Cash and investments $119M, no debt; operating cash flow $3.6M in Q3.
- NexoBrid BLA resubmission expected mid-2022; MACI biopsies growth >30% expected in 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000162828021022408/0001628280-21-022408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000162828021022408/vcel-20211109.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-022408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer